Association between colonoscopy and colorectal cancer occurrence and mortality in the older population: a population-based cohort study

Ji Young Lee; Jae Myung Cha; Jin Young Yoon; Min Seob Kwak; Hun Hee Lee

doi:10.1055/a-2463-1737

Endoscopy, Inhaltsverzeichnis

Endoscopy
DOI: 10.1055/a-2463-1737

Original article

Association between colonoscopy and colorectal cancer occurrence and mortality in the older population: a population-based cohort study

Ji Young Lee

¹Health Screening and Promotion Center, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea (the Republic of)

,

Jae Myung Cha

²Department of Internal Medicine, Kyung Hee University Hospital at Gang Dong, College of Medicine, Kyung Hee University, Seoul, Korea (the Republic of)

,

Jin Young Yoon

²Department of Internal Medicine, Kyung Hee University Hospital at Gang Dong, College of Medicine, Kyung Hee University, Seoul, Korea (the Republic of)

,

Min Seob Kwak

²Department of Internal Medicine, Kyung Hee University Hospital at Gang Dong, College of Medicine, Kyung Hee University, Seoul, Korea (the Republic of)

,

Hun Hee Lee

³Big Data Center, Kyung Hee University Hospital at Gang Dong, Seoul, Korea (the Republic of)

› Institutsangaben

Abstract

Background

We aimed to evaluate the association between colonoscopy and colorectal cancer (CRC) occurrence and related mortality in an older population.

Methods

This retrospective, nationwide, population-based cohort study used data of adults aged ≥40 years from the Health Insurance Review and Assessment Service database. After excluding colonoscopy within 6 months of CRC diagnosis during enrollment, CRC occurrence and related mortality were compared between colonoscopy and non-colonoscopy groups using a time-dependent Cox proportional hazard model. Subgroup analysis was conducted among four age groups: young, middle-aged, old, and very old.

Results

Among 748986 individuals followed for 9.64 (SD 0.99) years, the colonoscopy group had a 65% lower CRC occurrence (adjusted hazard ratio [HRa] 0.35, 95%CI 0.32–0.38) and 76% lower CRC-related mortality (HRa 0.24, 95%CI 0.18–0.31) after 5 years compared with the non-colonoscopy group. Colonoscopy was associated with the most significant reduction in CRC occurrence in the middle-aged group (HRa 0.32, 95%CI 0.29–0.35) and in CRC-related mortality in the young group (HRa 0.04, 95%CI 0.01–0.33); the very old group had the least reduction in both CRC occurrence and CRC-related mortality (HRa 0.44, 95%CI 0.33–0.59 and HRa 0.28, 95%CI 0.15–0.53, respectively).

Conclusion

We found a significant association between colonoscopy and reduction in CRC occurrence and CRC-related mortality in adults aged ≥40 years after 5 years of follow-up; however, these associations were weaker in the very old group. More research is needed on the association between colonoscopy and older age.

Volltext

Referenzen

References
1 Doubeni CA, Corley DA, Quinn VP. et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut 2018; 67: 291-298
2 Kahi CJ, Pohl H, Myers LJ. et al. Colonoscopy and colorectal cancer mortality in the Veterans Affairs health care system: a case-control study. Ann Intern Med 2018; 168: 481-488
3 Manser CN, Bachmann LM, Brunner J. et al. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc 2012; 76: 110-117
4 Nishihara R, Wu K, Lochhead P. et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013; 369: 1095-1105
5 Sung JJ, Ng SC, Chan FK. et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut 2015; 64: 121-132
6 Davidson KW, Barry MJ. US Preventive Services Task Force. et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 325: 1965-1977
7 Kim Y, Jun JK, Choi KS. et al. Overview of the National Cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev 2011; 12: 725-730
8 Cha JM, Kwak MS, Kim HS. et al. Real-world national colonoscopy volume in Korea: a nationwide population-based study over 12 years. Gut Liver 2020; 14: 338-346
9 Suh M, Song S, Cho HN. et al. Trends in participation rates for the national cancer screening program in Korea, 2002–2012. Cancer Res Treat 2017; 49: 798-806
10 Cha JM. Would you recommend screening colonoscopy for the very elderly?. Intest Res 2014; 12: 275-280
11 Lieberman DA, Williams JL, Holub JL. et al. Colonoscopy utilization and outcomes 2000 to 2011. Gastrointest Endosc 2014; 80: 133-143 e3
12 Cheol Seong S, Kim YY, Khang YH. et al. Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol 2017; 46: 799-800
13 Hwang YJ, Kim N, Yun CY. et al. Validation of administrative big database for colorectal cancer searched by international classification of disease 10th codes in Korean: a retrospective big-cohort study. J Cancer Prev 2018; 23: 183-190
14 Baxter NN, Warren JL, Barrett MJ. et al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 2012; 30: 2664-2669
15 Lim S, Marcus SM, Singh TP. et al. Bias due to sample selection in propensity score matching for a supportive housing program evaluation in New York City. PLoS One 2014; 9: e109112
16 Quan H, Li B, Couris CM. et al. Updating and validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge abstracts using data from 6 countries. Am J Epidemiol 2011; 173: 676-682
17 Fisher LD, Lin DY. Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 1999; 20: 145-157
18 Zauber AG, Winawer SJ, O’Brien MJ. et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366: 687-696
19 Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-2270
20 García-Albéniz X, Hsu J, Bretthauer M. et al. Effectiveness of screening colonoscopy to prevent colorectal cancer among Medicare beneficiaries aged 70 to 79 years: a prospective observational study. Ann Intern Med 2017; 166: 18-26
21 Ma W, Wang K, Nguyen LH. et al. Association of screening lower endoscopy with colorectal cancer incidence and mortality in adults older than 75 years. JAMA Oncol 2021; 7: 985-992
22 Lin OS, Kozarek RA, Schembre DB. et al. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA 2006; 295: 2357-2365
23 Day LW, Kwon A, Inadomi JM. et al. Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis. Gastrointest Endosc 2011; 74: 885-896
24 Gatto NM, Frucht H, Sundararajan V. et al. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 2003; 95: 230-236
25 Lee JA, Chang Y, Kim Y. et al. Colonoscopic screening and risk of all-cause and colorectal cancer mortality in young and older individuals. Cancer Res Treat 2023; 55: 618-625
26 Jodal HC, Helsingen LM, Anderson JC. et al. Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis. BMJ Open 2019; 9: e032773
27 Shaukat A, Mongin SJ, Geisser MS. et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 2013; 369: 1106-1114
28 Shaukat A, Kaalby L, Baatrup G. et al. Effects of screening compliance on long-term reductions in all-cause and colorectal cancer mortality. Clin Gastroenterol Hepatol 2021; 19: 967-975 e2
29 Zheng S, Schrijvers JJA, Greuter MJW. et al. Effectiveness of colorectal cancer (CRC) screening on all-cause and CRC-specific mortality reduction: a systematic review and meta-analysis. Cancers (Basel) 2023; 15: 1948
30 Yoon JY, Kwak MS, Kim HI. et al. Seasonal variations in the diagnosis of the top 10 cancers in Korea: a nationwide population-based study using a common data model. J Gastroenterol Hepatol 2021; 36: 3371-3380
31 Berstad P, Løberg M, Larsen IK. et al. Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial. Gut 2015; 64: 1268-1276
32 Larsen IK, Grotmol T, Almendingen K. et al. Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial. Clin Gastroenterol Hepatol 2007; 5: 477-483
33 Carethers JM, Doubeni CA. Causes of socioeconomic disparities in colorectal cancer and intervention framework and strategies. Gastroenterology 2020; 158: 354-367
34 Fowler H, Belot A, Ellis L. et al. Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers. BMC Cancer 2020; 20: 2
35 Yoon SJ, Kim EJ, Seo HJ. et al. The Association between Charlson Comorbidity Index and the medical care cost of cancer: a retrospective study. Biomed Res Int 2015; 2015: 259341

Zusatzmaterial

Zusatzmaterial